LIVE: FDA Panel Considers COVID-19 Vaccines for Toddlers, Babies

On June 15, the Vaccines and Related Biological Products Advisory Committee will meet in an open session through an online teleconferencing platform to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age.

Find more info here.